Andy Acker is a Portfolio Manager on the Janus Global Life Sciences strategy, a position he has held since 2007. He also serves as co-team leader of the health care sector research team and as a Research Analyst covering the biotechnology sector. Mr. Acker served as assistant portfolio manager on the Global Life Sciences strategy from 2003 to 2007 and as co-portfolio manager of the Janus Aspen Global Life Sciences Portfolio from 2004 to 2007. Mr. Acker joined Janus in 1999 as a research analyst, focusing on companies in the biotechnology and pharmaceutical industries. Prior to Janus, he worked as a strategy consultant for the Boston Consulting Group and as a health care analyst for Morgan Stanley Venture Partners.
Mr. Acker received his bachelor of science degree in biochemical sciences from Harvard University, graduating magna cum laude and Phi Beta Kappa. He also earned an MBA from Harvard Business School, graduating with honors. Mr. Acker holds the Chartered Financial Analyst designation and has null years of financial industry experience.